UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 20, 2005
BIOVERIS CORPORATION
(Exact name of Registrant as specified in its charter)
|
Delaware |
000-50583 |
80-0076765 |
|
(State or Other Jurisdiction |
(Commission File Number) |
(I.R.S. Employer |
|
|
|
|
|
16020 Industrial Drive Gaithersburg, MD 20877 (Address of Principal Executive Offices) | ||
(301) 869-9800
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02 |
Departure of Directors or Principal Officers; Election of Directors; Appointment of | |
|
|
Principal Officers. |
|
On July 20, 2005, the Company announced the retirement of Dr. Richard J. Massey from his position as the Company’s President and Chief Executive Officer, effective August 1, 2005.
|
Item 8.01 |
Other Events. |
See attached Press Release of the Company, dated July 20, 2005, filed herewith as Exhibit 99.1.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: July 20, 2005 |
BIOVERIS CORPORATION
By: /s/ George V. Migausky Name: George V. Migausky Chief Financial Officer
|
|
|
|
EXHIBIT INDEX
|
Exhibit 99.1 |
Press Release of the Company, dated July 20, 2005 |
